Journal
BIOTECHNOLOGY ADVANCES
Volume 33, Issue 7, Pages 1395-1402Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.biotechadv.2015.02.011
Keywords
Synthetic biology; Metabolic engineering; Cell factories; Saccharomyces cerevisiae; Escherichia coli; Industrial production
Categories
Funding
- Div Of Chem, Bioeng, Env, & Transp Sys
- Directorate For Engineering [1149678] Funding Source: National Science Foundation
- NNF Center for Biosustainability [Yeast Cell Factories] Funding Source: researchfish
- Novo Nordisk Fonden [NNF10CC1016517, NNF14SA0013603] Funding Source: researchfish
Ask authors/readers for more resources
Industrial bio-processes for fine chemical production are increasingly relying on cell factories developed through metabolic engineering and synthetic biology. The use of high throughput techniques and automation for the design of cell factories, and especially platform strains, has played an important role in the transition from laboratory research to industrial production. Model organisms such as Saccharomyces cerevisiae and Escherichia coli remain widely used host strains for industrial production due to their robust and desirable traits. This review describes some of the bio-based fine chemicals that have reached the market, key metabolic engineering tools that have allowed this to happen and some of the companies that are currently utilizing these technologies for developing industrial production processes. (C) 2015 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available